Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cataract-glaucoma syndrome is characterized by the association of total bilateral congenital cataract with the secondary occurrence of glaucoma appearing at ages varying between 10 and 40 years.
Biomarker and diagnostic research for cataract-glaucoma syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for cataract-glaucoma syndrome.
55 publications have been identified in PubMed for cataract-glaucoma syndrome. Research spans Epidemiology / Natural History (48%), Review / Meta-Analysis (25%), and Case Report / Case Series (13%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 25 | 48% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:50 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
13 |
25% |
Patient case studies | 7 | 13% |
Testing and diagnosis research | 4 | 8% |
Clinical study results | 3 | 6% |
Jiang L (2026). [PMID: 42148323](https://pubmed.ncbi.nlm.nih.gov/42148323/). *J Cell Commun Signal*. [Review / Meta-Analysis]
Cui X (2026). [PMID: 42243112](https://pubmed.ncbi.nlm.nih.gov/42243112/). *NPJ Sci Food*. [Epidemiology / Natural History]
Lee YH (2026). [PMID: 41633654](https://pubmed.ncbi.nlm.nih.gov/41633654/). *Korean J Ophthalmol*. [Review / Meta-Analysis]
Mirzaliyeva L (2026). [PMID: 41640364](https://pubmed.ncbi.nlm.nih.gov/41640364/). *Histol Histopathol*. [Review / Meta-Analysis]
Anne RP (2026). [PMID: 42231307](https://pubmed.ncbi.nlm.nih.gov/42231307/). *BMC Pediatr*. [Review / Meta-Analysis]
Sun S (2026). [PMID: 41864486](https://pubmed.ncbi.nlm.nih.gov/41864486/). *Exp Eye Res*. [Review / Meta-Analysis]
Li J (2026). [PMID: 42251471](https://pubmed.ncbi.nlm.nih.gov/42251471/). *Optom Vis Sci*. [Epidemiology / Natural History]
Yu HN (2026). [PMID: 42159203](https://pubmed.ncbi.nlm.nih.gov/42159203/). *Ophthalmic Epidemiol*. [Epidemiology / Natural History]
Karri R (2026). [PMID: 42082325](https://pubmed.ncbi.nlm.nih.gov/42082325/). *Br J Ophthalmol*. [Review / Meta-Analysis]
Cohen SA (2026). [PMID: 41496654](https://pubmed.ncbi.nlm.nih.gov/41496654/). *Curr Opin Ophthalmol*. [Review / Meta-Analysis]